Skip to main content
logo
Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
66.60
+14.50 (27.83%)
Jul 21, 2026, 4:08 PM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Pharmaceuticals
102.10M11.83M199.65M
Pharmaceuticals Growth
762.88%-94.07%-
Total
102.10M11.83M199.65M
Total Growth
762.88%-94.07%-

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
People's Republic of China (PRC)
101.94M11.79M198.98M
People's Republic of China (PRC) Growth
764.63%-94.07%-
Uzbekistan
156.00K42.00K674.00K
Uzbekistan Growth
271.43%-93.77%-
Total
102.10M11.83M199.65M
Total Growth
762.88%-94.07%-